2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Suspended
1
Sponsor Class
NETWORK
1
Study Type
Interventional
1
Sponsor
Conditions
Multiple Myeloma
14
Lymphoma, Non-Hodgkin
10
Carcinoma, Non-Small-Cell Lung
7
Breast Neoplasms
7
Arthritis, Rheumatoid
7
Lymphoma, Large B-Cell, Diffuse
5
Lymphoma, B-Cell
5
Lymphoma
5
Solid Tumors
4
Recurrence
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
Neoplasms
4
Melanoma
4
Leukemia, Myeloid, Acute
4
Leukemia, Lymphocytic, Chronic, B-Cell
4
Colorectal Neoplasms
4
Ovarian Neoplasms
3
Lymphoma, Follicular
3
Leukemia
3
Hematologic Neoplasms
3
Cytokine Release Syndrome
3
Burkitt Lymphoma
3
Urinary Bladder Neoplasms
2
Respiratory Distress Syndrome
2
Pancreatic Neoplasms
2
Myelodysplastic Syndromes
2
Lymphoma, Mantle-Cell
2
Fallopian Tube Neoplasms
2
Craniopharyngioma
2
Carcinoma, Hepatocellular
2
Interventions
tocilizumab
1
lopinavir-ritonavir drug combination
1
Piperacillin, Tazobactam Drug Combination
1
Oxygen Inhalation Therapy
1
Methylprednisolone
1
Lopinavir
1
Hydroxychloroquine
1
Heparin, Low-Molecular-Weight
1
Azithromycin
1
Adrenal Cortex Hormones
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Pneumonia, Viral
×
tocilizumab
×
Clear all
NCT04394182
2022-03-29
ULTRA-COVID
Fundacion GenesisCare
Phase NA
Suspended
15 enrolled